| Release Date |
Topic |
| April 13, 2021 |
Negotiating Skills and Strategies |
| February 25, 2021 |
Grounded Theory in Medical Education Research |
|
January 15, 2021
|
Town Hall on NIH-organized Trials of Antithrombotic Agents in Patients with COVID-19: Hear the Latest and Become Involved in ACTIV-4
|
| January 12, 2021 |
ASH ISTH NHF WFH 2021 Guidelines on the Diagnosis and Management of Von Willebrand Disease Webinar |
| December 15, 2020 |
Writing a Good Letter of Recommendation |
| November 23, 2020 |
ASH Practice Partnership Session - To CAM or Not To, That is the Question; Complementary and Alternative Medicine in Hematology |
| November 20, 2020 |
Sickle Cell Disease (SCD) and COVID Management in the ED |
| November 19, 2020 |
MEI Developing an Assessment Tool |
| November 18, 2020 |
ASH Grassroots Network Session |
|
November 17, 2020
|
ASH 2020 Guidelines for Treating Newly Diagnosed Acute Myeloid Leukemia in Older Adults
|
| October 8, 2020 |
ASH Guidelines on Use of Anticoagulation in Patients with COVID-19 |
| October 8, 2020 |
Congressional Briefing: National Academies Report - Addressing Sickle Cell Disease |
| September 24, 2020 |
Implicit Bias and Health Equity |
| September 14, 2020 |
ASH Advocacy 101 |
| August 10, 2020 |
Cutting-edge Teaching Techniques in Medical Education |
|
July 8, 2020
|
Designing Effective Curriculums in Medical Education |
| June 29, 2020 |
Addressing the Global Burden of Sickle Cell Disease During the COVID-19 Pandemic and Beyond |
|
June 25, 2020
|
ASH Webinar on COVID-19 and Thrombosis
|
|
June 19, 2020
|
Systems-Based Hematology and Medical Education
|
|
June 4, 2020
|
Technology and Large Group Teaching in Times of Distance Learning
|
|
May 12, 2020
|
What kinds of administrative roles are there within medical education? How do I know if that type of career is right for me?
|
|
May 12, 2020
|
The Use of Convalescent Plasma During COVID-19
|
| April 13, 2020 |
Telehealth During COVID-19 |
|
February 26, 2020
|
Burnout: Balancing Educational, Clinical, and Scholarly Activities
|
|
February 5, 2020
|
Coaching the Problem Learner
|
| November 21, 2019 |
Leveraging New Technologies: The Ins & Outs of E-Consults and Telemedicine
|
| October 28, 2019 |
How to survive ASH with the ASH Trainee Council
|
| July 25, 2019 |
Hydroxyurea for SCD Treatment
|
| March 10, 2019 |
Using Surveys as a Medical Educator for Assessing Learner Needs and Program Evaluation
|
| January 30 , 2019 |
Developing Multiple Choice Questions and Tests |
| April 18, 2018 |
Converting Teaching into Educational Scholarship through Publishing |
| April 5, 2018 |
Clinical Research Training Institute Mentorship Program |
| April 5, 2018 |
Promoting Faculty Well Being in an Academic Health Center |
| November 13, 2017 |
5 Steps to MIPS Registry Reporting for Hematologists |
| September 21, 2017 |
Coding for Sickle Cell Disease |
| September 5, 2017 |
ASH Preview of the 2017 Meeting on Hematologic Malignancies: Focus on Myeloproliferative Neoplams/CML |
| July 31, 2017 |
How to Develop a CV |
| June 16, 2017 |
Treating AML: Current and Novel Approaches (ASH-LLS) |
| January 11, 2017 |
ASH Preview of the Meeting on Hematologic Malignancies: Focus on Myeloma |
| November 15, 2016 |
MACRA 101 for Hematologists |
| November 3, 2016 |
ASH Preview of the 2017 Meeting on Hematologic Malignancies: Focus on Lymphoma |
| August 31, 2016 |
ASH Presents an Exclusive Preview of the 2016 Meeting on Hematologic Malignancies |
| August 9, 2016 |
ASH-FDA Update on Nivolumab |
| July 29, 2016 |
ASH-FDA Update on Venetoclax |
| June 29, 2016 |
ASH-FDA Update on Ixazomib |
| June 17, 2016 |
ASH-FDA Update on Daratumumab |
| May 18, 2016 |
ASH-FDA Update on Idarucizumab |
| May 16, 2016 |
ASH-FDA Update on von Willebrand factor (Recombinant) |
| March 14, 2016 |
ASH-FDA Update on Elotuzumab |
| February 11, 2016 |
ASH-FDA Update on Eltrombopag for Treatment of Children with Chronic Immune Thrombocytopenia (ITP) |